5Barlogie B, Raber MN, Schumarm J, et al. Flow cytometry in clinic cancer research. Cancer Res, 1983,43:3982-3997.
6Dyszkiewicz W, Kasprzyk M, Piwkowski C, et al. The prognostic value of DNA content analysis in patients with squamous cell lung Cancer treated surgicallv, Lung Cancer, 2000,29: 161-167.
7Costa A, Silvestrini R, Mochen C, et al. p53 expression, DNA ploidy and S-phase cell fraction in operable locally advanced non-small-cell lung.cancer. Br J Cancer, 1996,73:914-919.
8lsobe H, Miyamoto H, Shimizu T, et al. Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer. Cancer, 1990,65: 1391-1395.
9Dyszkiewicz W, Kasprzyk M, Piwkowski C, et al. Prognostic significance of DNA ploidy in squamous cell lung carcinoma: is it really worth it? Ann Thorac Surg , 2000,70:1629-1633.
10Jeanfaivre T, Chassevent A, Geslin J, et al. Prognostic value of flow cytometry in squamous cell bronchogenic cancer: a retrospective study of 61 cases. Bull Cancer, 1997,84:597-602.
